MissionIR Articles
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Major Software Enhancement for Barocycler 2320EXTREME Instrument
Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced the release of extensively redesigned…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Acquires All Assets of BaroFold, Inc.
Pressure BioSciences (OTCQB: PBIO) today reported the acquisition of all assets of BaroFold, Inc. The assets acquired include all patents, equipment, and intellectual property relating to BaroFold’s PreEMT™ high-pressure protein refolding technology. A total of…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science
Amid the requirements for maintaining uncompromised sampling in laboratory research, Pressure BioSciences, Inc. (PBIO) is delivering a proprietary technology that can control the preparation of scientific samples in a critical and unprecedented way. This allows…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Targets Nanoemulsions Market Through Collaboration with Phasex Corp.
Pressure BioSciences (OTCQB: PBIO) recently entered into a strategic collaboration with Phasex Corporation. The company’s goal is to combine its patented Ultra Shear Technology (“UST”) with Phasex’ Supercritical Fluid (“SCF”) processing to cultivate stable, water-soluble…
-
Pressure BioSciences Inc. (PBIO) Forms Strategic Collaboration with Phasex Corporation to Address Markets for Nanoemulsions
Goal is to combine PBIO’s patented Ultra Shear Technology (UST) with Phasex’ Supercritical Fluid (SCF) processing to develop stable, water-soluble nanoemulsions As part of this collaboration, PBIO and Phasex seek to develop stable, water-soluble nanoemulsions…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Q3 Top Line Marks Record Quarterly Growth
Pressure BioSciences (OTCQB: PBIO) capitalized on a strong demand for its proprietary pressure-based laboratory instruments and related products, reporting record quarterly revenues of more than $600,000 for Q32017. An article discussing this reads: “Among recent…
-
Pressure BioSciences, Inc. (PBIO) Achieves Record Quarterly Revenue Growth
Quarterly total revenue exceeds $600,000 for the first time ever Consumable sales up 158 percent year-over-year New Center of Excellence in Asia expected to speed expansion in China Recently patented Ultra Shear Technology platform can…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Posts Q3 2017 Financial Results, Provides Business Update
Pressure BioSciences (OTCQB: PBIO) (“PBI”) reported financial results for the third quarter of 2017 today, along with a business update and limited guidance regarding its expected revenue for the rest of FY 2017. Among other…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference Regarding Q3 2017 Financial Results
Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, announced this morning that the company will host a conference call, during which…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Progresses in Global Life Sciences Industry
Pressure BioSciences, Inc. (OTCQB: PBIO) is engaged in the development and sale of innovative solutions for the worldwide life sciences industry. The company is advancing in the industry, with its patented high pressure cycling technology.…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Names First Center of Excellence in China, Eyes Significant Expansion
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced that Professor Tiannan Guo’s…
-
Pressure BioSciences, Inc. (PBIO) Game-Changing Pressure Cycling Technology Is Revolutionizing Scientific Research at the Most Fundamental Level
Company is positioned to disrupt the $6 billion global life sciences sample preparation market Pressure Cycling Technology (PCT) is a game-changer in bolstering the quality and efficacy of scientific research Next generation Barocycler 2320EXTREME instrument…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters Collaboration Agreement with Phasex Corporation
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced…
-
Pressure BioSciences Inc. (PBIO) is “One to Watch”
Poised to disrupt sciences sample preparation market estimated at $6 billion Nearly 300 patented enabling technology platform products installed at more than 150 sites worldwide Two patents awarded in China for Ultra Shear Technology used…
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option